跳至主要内容
临床试验/NCT05288751
NCT05288751进行中(未招募)不适用

Contingency Management as a Treatment for Opioid Use Disorder and Stimulant Use Disorder in a Primary Care Setting

University of Minnesota2 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2022年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
56
试验地点
2
主要终点
Preliminary efficacy of CM on clinical outcomes: Visit Frequency

研究概览

简要总结

Contingency management (CM) is a behavioral intervention that involves incentivizing participants for target behaviors in a clinical setting. When applied to the treatment of substance use disorders, it has demonstrated efficacy in reducing the number of urine toxicology screens positive for illicit substances and increased engagement in treatment programs. However, there is a need to translate CM treatment to primary care settings. This study will implement and assess a CM program for patients with opioid use disorder, with or without comorbid stimulant use disorder, initiating outpatient addiction medicine services at a family medicine residency clinic. Eligible patients will earn monetary incentives for attending addiction medicine appointments and abstaining from substances during outpatient treatment. Data gathered from this pilot program will be used to improve patient outcomes, treatment, and retention for persons receiving medications for opioid use disorder (MOUDs) in a primary care setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age
  • Diagnosis of Opioid Use Disorder and/or Stimulant Use Disorder
  • Recently initiated medications for opioid use disorder (MOUDs) at Broadway Family Medicine (BFM), within 2 weeks of recruitment
  • Have an active prescription for buprenorphine-naloxone (Suboxone)

排除标准

  • Prescription for an amphetamine would exclude patients from the abstinence-based CM, but they could participate in the attendance-only CM.
  • Dementia, development disabilities, or cognitive functioning that is too low to participate in study measures, as determined by chart review and consultation with overseeing physician.

结局指标

主要结局

Preliminary efficacy of CM on clinical outcomes: Visit Frequency

时间窗: 30 days post-intervention

Number of completed clinical visits per patient during the CM program.

Feasibility of CM for OUD in primary care: Retention

时间窗: 30 days post-intervention

Of those patients who enroll in the intervention study, the percent that complete the CM intervention period.

Preliminary efficacy of CM on clinical outcomes: Urine toxicology

时间窗: 30 days post-intervention

Percentage of UDS results that are negative for stimulants during the CM intervention period.

Feasibility of CM for OUD in primary care: Recruitment

时间窗: 30 days post-intervention

percentage of patients invited to participate enroll in the treatment intervention.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验